ACTG Announces the Addition of Two Monoclonal Antibodies to ACTIV-2 Outpatient Treatment Study for COVID-19

Link Type

Funded-research

Media Type

Article

Publish or Event Date

Wed, 06/09/2021 - 12:00pm

Link URL

https://actgnetwork.org/2021/06/09/actg-announces-the-addition-of-two-monoclonal-antibodies-to-activ-2-outpatient-treatment-study-for-covid-19/

Research Institution

AIDS Clinical Trials Group (ACTG)

Short Title

ACTG Announces the Addition of Two Monoclonal Antibodies to ACTIV-2 Outpatient Treatment Study for COVID-19

Content Coordinator

Content Manager

For Researchers